Mechanistic work suggests that tri-agonist signaling may influence several components of glucose regulation, including insulin secretion pathways, hepatic glucose handling, and peripheral metabolic signaling
In the critical realm of cardiovascular health, the clinical evidence supporting L-carnitine supplementation is particularly robust and compelling
FDA-approved candidates include adults with BMI 30 kg/m or BMI 27 kg/m with weight-related comorbidities such as hypertension, dyslipidemia, or cardiovascular disease
A new report supports lower GLP-1 levels related to gut microbiome dysregulation @Cell_Metabolism cell.com/cell-metabolis When I spotlighted the concern about statins and diabetes many years ago, the push back was profound
Before diving into these questions, its important to establish some basic facts about the spread of GLP-1 prescriptions for weight loss
Importantly, patients taking medications that increase potassium levels, such as ACE inhibitors, angiotensin receptor blockers (ARBs), or potassium-sparing diuretics, should avoid potassium supplements unless specifically advised by their healthcare provider